We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Healthcare professionals prescribing fluoroquinolone antibiotics (ciprofloxacin, delafloxacin, levofloxacin, moxifloxacin, ofloxacin) are reminded to be alert to the risk of disabling and potentially long-lasting or irreversible side effects. Do not prescribe fluoroquinolones for non-severe or self-limiting infections, or for mild to...
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
There have been very rare reports of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) with pseudoephedrine.
Further measures to be introduced to ensure patients who are prescribed montelukast for the treatment of asthma are informed of the risk of neuropsychiatric reactions
How a marketing authorisation holder should report a defect with a veterinary medicine.
Explainer for the pharmaceutical industry on Pharmacovigilance requirements mitigations to bridge the gap between the implementation of the EU Regulation on veterinary medicines and the revised Veterinary Medicines Regulations as they have an effect in Great Britain (GB VMR).
How marketing authorisation holders should inform MHRA of a signal or an ADR to a medicine.
Find out what online harms are, how to manage them, and where to report them if they occur.
Advises on how to consider light within the planning system.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
A guide to farming risks, potential problems with public safety and how to avoid accidents
How a competent authority must decide if a plan or project proposal that affects a European site can go ahead.
We are providing an update on a retrospective observational study on the risk to children born to men who took valproate in the 3 months before conception and on the need for the re-analysis of the data from this study...
Advice to give pregnant women on infections that can be transmitted via contact with animals that are or have recently given birth.
Ectoparasiticide veterinary medicinal products and reporting adverse events.
When you need to do an environmental risk assessment, when the Environment Agency will do it for you, and how to do a risk assessment.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.